Stay updated on Ampion Therapy in Adult COVID-19 Patients Clinical Trial
Sign up to get notified when there's something new on the Ampion Therapy in Adult COVID-19 Patients Clinical Trial page.

Latest updates to the Ampion Therapy in Adult COVID-19 Patients Clinical Trial page
- ChecktodayChange DetectedRevision label updated from v3.3.3 to v3.3.4; no study data or core content appears to be affected.SummaryDifference0.1%

- Check7 days agoNo Change Detected
- Check14 days agoNo Change Detected
- Check21 days agoChange DetectedFooter updates: the page now displays 'Revision: v3.3.3' and the 'HHS Vulnerability Disclosure' link and the 'Revision: v3.3.2' mention were removed. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check50 days agoChange DetectedThe revision label changed from v3.2.0 to v3.3.2, with no other changes to trial details or page content; To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check57 days agoChange DetectedThe government funding status notice/banner was removed from the page. This does not affect the study data or enrollment details.SummaryDifference0.4%

- Check72 days agoChange DetectedNew screenshot shows a UI redesign with updated layout and visuals, while all trial data (outcome measures, eligibility criteria, study dates, and recruitment status) remain unchanged. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check100 days agoChange DetectedAdded a government-status notice and version v3.2.0; removed the previous version v3.1.0.SummaryDifference7%

Stay in the know with updates to Ampion Therapy in Adult COVID-19 Patients Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Ampion Therapy in Adult COVID-19 Patients Clinical Trial page.